Global High Throughput Screening (HTS) Service Market Growth (Status and Outlook) 2025-2031

The global High Throughput Screening (HTS) Service market size is predicted to grow from US$ 302 million in 2025 to US$ 550 million in 2031; it is expected to grow at a CAGR of 10.5% from 2025 to 2031.

To carry out high-throughput screening experiments, facilities often employ automated instruments and liquid handlers in order to test many samples quickly and efficiently. High-throughput screening (HTS) services offer researchers easy access to the experience, expertise, and instrumentation needed to conduct a variety of assays to advance processes in drug discovery and development. HTS applications include enzyme activity assays, molecular binding assays, protein-protein interactions, gene expression screening, compound library screening, cell-based assays, and GPCR assays. HTS-based services often can be tailored to customized requests and the unique requirements of the project. Service providers can also provide technical and scientific advice from the early stages of the project to completion and data analysis.

The world's core manufacturers of High Throughput Screening (HTS) Service include Eurofins Discovery, Charles River Laboratories and Axcelead. The top three companies have a market share of about 24 percent. The United States and Canada are the world's largest High Throughput Screening (HTS) Service market with a market share of about 46%, followed by China and Europe with a market share of 19% and 15%, respectively. In terms of product type, Chemical-based HTS Service is the largest segment with approximately 40% market share. In terms of application, Pharmaceutical Industry is the largest downstream segment, accounting for about 80% of the market.

LPI (LP Information)' newest research report, the “High Throughput Screening (HTS) Service Industry Forecast” looks at past sales and reviews total world High Throughput Screening (HTS) Service sales in 2024, providing a comprehensive analysis by region and market sector of projected High Throughput Screening (HTS) Service sales for 2025 through 2031. With High Throughput Screening (HTS) Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world High Throughput Screening (HTS) Service industry.

This Insight Report provides a comprehensive analysis of the global High Throughput Screening (HTS) Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on High Throughput Screening (HTS) Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global High Throughput Screening (HTS) Service market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for High Throughput Screening (HTS) Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global High Throughput Screening (HTS) Service.

This report presents a comprehensive overview, market shares, and growth opportunities of High Throughput Screening (HTS) Service market by product type, application, key players and key regions and countries.

Segmentation by Type:

Chemical-based HTS Service

Biological-based HTS Service

Cell-based HTS Service

Genetic-based HTS Service

Segmentation by Application:

Pharmaceutical Industry

Universities and Scientific Research Institutions

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

Eurofins Discovery

Charles River Laboratories

Axcelead

NUVISAN

Axxam S.p.A.

Evotec

Selvita

Azenta Life Sciences

Bienta (Enamine)

Cayman Chemical

Creative Biolabs

Creative Bioarray

BOC Sciences

MEDICILON

Domainex

Creative Diagnostics

Multispan

AntalGenics

Creative Biostructure

BPS Bioscience

Please note: The report will take approximately 2 business days to prepare and deliver.